645 related articles for article (PubMed ID: 25839785)
21. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
[TBL] [Abstract][Full Text] [Related]
22. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
Xue K; Qian J; Yue H; Yuan YF; Zhang R
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous regression of retinoblastoma in a Taiwan series.
Kao LY; Yang ML
J Pediatr Ophthalmol Strabismus; 2005; 42(4):228-32. PubMed ID: 16121553
[TBL] [Abstract][Full Text] [Related]
24. Retinoblastoma in the Beijing Tongren Hospital from 1957 to 2006: clinicopathological findings.
Bai S; Ren R; Shi J; Xu X; Zhao J; Gao F; Li L; Shen L; Li B; Jonas JB
Br J Ophthalmol; 2011 Aug; 95(8):1072-6. PubMed ID: 20644215
[TBL] [Abstract][Full Text] [Related]
25. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.
Eagle RC; Shields CL; Bianciotto C; Jabbour P; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1416-21. PubMed ID: 21746972
[TBL] [Abstract][Full Text] [Related]
27. Incidental finding of double nodular microscopic hyperplasia versus adenoma of the retinal pigment epithelium in an eye eviscerated for phthisis bulbi.
Abdolrahimzadeh S; Garzione F; Cruciani F; Rahimi S
Clin Ter; 2010; 161(5):449-51. PubMed ID: 20949242
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
[TBL] [Abstract][Full Text] [Related]
29. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country.
Orellana ME; Fernandes BF; Arean C; Pifano I; Al-Kandari A; Burnier MN
J Pediatr Ophthalmol Strabismus; 2009; 46(5):294-9. PubMed ID: 19791727
[TBL] [Abstract][Full Text] [Related]
30. Orbito-ocular lesions in Lagos.
Anunobi CC; Akinsola FB; Abdulkareem FB; Aribaba OT; Nnoli MA; Banjo AA
Niger Postgrad Med J; 2008 Sep; 15(3):146-51. PubMed ID: 18923586
[TBL] [Abstract][Full Text] [Related]
31. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
Radhakrishnan V; Kashyap S; Pushker N; Sharma S; Pathy S; Mohanti BK; Vishnubhatla S; Ghose S; Bakhshi S
Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
[TBL] [Abstract][Full Text] [Related]
32. Cavitary changes in retinoblastoma: relationship to chemoresistance.
Mashayekhi A; Shields CL; Eagle RC; Shields JA
Ophthalmology; 2005 Jun; 112(6):1145-50. PubMed ID: 15885779
[TBL] [Abstract][Full Text] [Related]
33. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
[TBL] [Abstract][Full Text] [Related]
34. An observational study on retinoblastoma cases attending a medical college in Calcutta.
Mukhopadhyay S; Ghosh S; Chattopadhyay D; Dutta SK
J Indian Med Assoc; 2006 Feb; 104(2):67-70. PubMed ID: 16856584
[TBL] [Abstract][Full Text] [Related]
35. Differentiation in retinoblastoma and histopathological risk factors in Mexico.
Gómez-Martínez R; Rosales-Gradilla ME; Silva-Padilla N; Corona-Macías A
J Pediatr Ophthalmol Strabismus; 2013; 50(3):174-7. PubMed ID: 23477342
[TBL] [Abstract][Full Text] [Related]
36. Dystrophic hyaloid artery remnants and other abnormalities in a buphthalmic eye with retinoblastoma.
Jakobiec FA; Rai R; Rashid A; Kanoff J; Mukai S
Surv Ophthalmol; 2014; 59(6):636-42. PubMed ID: 25233827
[TBL] [Abstract][Full Text] [Related]
37. Eye size in retinoblastoma: MR imaging measurements in normal and affected eyes.
de Graaf P; Knol DL; Moll AC; Imhof SM; Schouten-van Meeteren AY; Castelijns JA
Radiology; 2007 Jul; 244(1):273-80. PubMed ID: 17581906
[TBL] [Abstract][Full Text] [Related]
38. Retinal neovascularization associated with retinoblastoma.
Shuler RK; Hubbard GB; Grossniklaus HE
Am J Ophthalmol; 2005 Jan; 139(1):210-2. PubMed ID: 15652861
[TBL] [Abstract][Full Text] [Related]
39. Distribution of phthisis bulbi and status of fellow eyes at a tertiary eye-care centre in Nigeria: a ten-year review.
Adewara BA; Badmus SA; Olugbade OT; Ezeanosike E; Adegbehingbe BO
Afr Health Sci; 2021 Mar; 21(1):437-444. PubMed ID: 34394326
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic variability of retinocytomas: preregression and postregression growth patterns.
Abouzeid H; Balmer A; Moulin AP; Mataftsi A; Zografos L; Munier FL
Br J Ophthalmol; 2012 Jun; 96(6):884-9. PubMed ID: 22328814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
